The Efficacy and Safety of Electronic Stimulation in Patients Who Underwent Reconstruction of the Anterior Cruciate Ligament

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to evaluate the efficacy and safety of Myospare, a non-invasive device, which is connected to the body via electrodes placed in the injured leg. The electrodes which are placed in the middle or upper thigh will stimulate the quadriceps muscle.

Myospare will be installed 1 day after the anterior cruciate ligament (ACL) reconstruction surgery and will be removed after 6 weeks of treatment. The patients will be assigned to two groups:

1. Physiotherapy plus Myospare
2. Only physiotherapy

The hypothesis of the study is that electrical stimulation combined with voluntary exercise is more effective than voluntary exercise alone.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness of a Session of Analgesic Electrostimulation (Invasive and Non-invasive) Applied to the Quadriceps Muscle in Patients After Knee Surgery.

NCT06910150

Anterior Cruciate Ligament Reconstruction Rehabilitation

ENROLLING_BY_INVITATION NA

Effect of All-Stim 2 Quadriceps Treatments on Limb Muscle Strength In Mechanically Ventilated Patients

NCT02332187

Weakness

TERMINATED NA

Efficacy of the SurgiStim3 Electrical Stimulation Device in Persons Undergoing Anterior Cruciate Ligament Repair

NCT00717171

Anterior Cruciate Ligament

TERMINATED PHASE4

Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome

NCT03184545

Patellofemoral Pain Syndrome

RECRUITING PHASE3

Dynamic Quadriceps Muscle Stimulation for Treatment of Patellofemoral Pain

NCT02243332

Patellofemoral Pain Syndrome Anterior Knee Pain Syndrome

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

stimulation of the quadriceps muscle with Myospare

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Males and females between 18-40 years old.
2. Subjects who are planning to undergo ACL surgery.
3. The surgery is performed within 3 weeks - 5 years since the injury.
4. Ability to follow instructions during the study period.
5. Signed Informed Consent.

Exclusion Criteria

1. Bi-lateral surgery of the knee
2. Recurrent ACL surgery (patients who already underwent ACL surgery)
3. Complex injuries (a combination of posterior and anterior cruciate and lateral ligament injury)
4. Patients who underwent or are planned to undergo cartilage implantation.
5. Patients who underwent or are planned to undergo meniscus stitching.
6. Additional fracture/s in the lower limbs as a result of the same injury.
7. Signs of infection in the surgical wounds while installing the Myospare device.
8. Known skin hypersensitivity.
9. Known heart disease
10. Patients with a cardiac pacemaker.
11. History of peripheral blood vessel disease
12. Administration of drugs which might disrupt bone metabolism:

* Total accumulating dosage of 150 gr' prednisone or any other glucocorticoid for seven days or more, within 6 months prior to the trial.
* Calcitonin for 7 days or more, within 6 months prior to the trial.
* Bisphosphonates for 30 days or more within 12 months prior to the study.
* Fluoride for bone strengthening for 30 days or more within 12 months prior to the study.
* Vitamin D or vitamin D metabolite for bone strengthening for 30 days or more within 12 months prior to the study.
* Current treatment with chemotherapeutic drugs.
13. Past or current malignant disease within 10 years of study entry.
14. Participating in another clinical study during the past four weeks.
15. Patients who are planned to undergo femoral nerve block.
16. Patients claiming social security/work accident benefits.
17. Professional athletes whose livelihood depends on sports.
18. Pregnant and or lactating women.
19. Additional symptoms, which in the doctor's opinion would prevent inclusion of the patient in the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No